Aduro Biotech (NASDAQ:ADRO) Is a Company that Oppenheimer Seems to Dislike as Downgrade in Given
Aduro Biotech (NASDAQ:ADRO) Receives a Downgrade Aduro Biotech (NASDAQ:ADRO) was cut by analysts at Oppenheimer from their past Outperform rating to a Perform rating in…
